Aim: To present a personal account of the involvement of the World Health Organization (WHO) in the collaborativedevelopment in Asia of those areas of andrology concerned with male contraception and reproductive healt...Aim: To present a personal account of the involvement of the World Health Organization (WHO) in the collaborativedevelopment in Asia of those areas of andrology concerned with male contraception and reproductive health.Methods: The andrology training through workshops and institution support undertaken by the WHO HumanReproduction Programme (HRP) and how they contributed to the strengthening of andrology research in Asia aresummarised. Results: The author's experience and the Asian scientific contributions to the global research in thefollowing areas are reviewed: the safety of vasectomy and the development of new methods of vas occlusion; gossypoland its failure to become a safe, reversible male antifertility drag; Tripterygium and whether its pure extracts will passthrough the appropriate toxicology and phased clinical studies to become acceptable contraceptive drugs; hormonalmethods of contraception for men. Conclusion: The WHO policy of research capacity building through training andinstitution strengthening, together with the collaboration of Asian andrologists, has created strong National institutionsnow able to direct their own programmes of research in clinical and scientific andrology.展开更多
Objective To determine the social and biological characteristics of Implanon acceptors at Ibadan Nigeria, and also to describe reasons why they opt for this choice and their concerns. Methods This was a descriptive st...Objective To determine the social and biological characteristics of Implanon acceptors at Ibadan Nigeria, and also to describe reasons why they opt for this choice and their concerns. Methods This was a descriptive study that retrospectively reviewed all records of the Implanon acceptors from January 2006 to December 2009 at University College Hospital Ibadan, Nigeria. Results One hundred and twenty-eight women accepted Implanon as a modern contraception accounting 4.3% of the total number of clients seen （2 972） during the period. The age range of the client that accepted Implanon was 26-43 years with a mean of 33.6 ±2.4 years. Of the 128 Implanon acceptors, 101 （78.9%） had used other contraceptive methods before. The commonest reason for switching to Implanon by clients was failure of the contraceptive method that was previously used （32.7%）. Within the first year follow-up of insertion, none of the Implanon acceptors had expressed desire for removal due to any of the side effects, and none contraceptive failure was observed during their follow-up evaluation. Conclusion The findings suggest that Implanon could safely be used by all women of reproductive age group including those who desire future fertility.展开更多
文摘Aim: To present a personal account of the involvement of the World Health Organization (WHO) in the collaborativedevelopment in Asia of those areas of andrology concerned with male contraception and reproductive health.Methods: The andrology training through workshops and institution support undertaken by the WHO HumanReproduction Programme (HRP) and how they contributed to the strengthening of andrology research in Asia aresummarised. Results: The author's experience and the Asian scientific contributions to the global research in thefollowing areas are reviewed: the safety of vasectomy and the development of new methods of vas occlusion; gossypoland its failure to become a safe, reversible male antifertility drag; Tripterygium and whether its pure extracts will passthrough the appropriate toxicology and phased clinical studies to become acceptable contraceptive drugs; hormonalmethods of contraception for men. Conclusion: The WHO policy of research capacity building through training andinstitution strengthening, together with the collaboration of Asian andrologists, has created strong National institutionsnow able to direct their own programmes of research in clinical and scientific andrology.
文摘Objective To determine the social and biological characteristics of Implanon acceptors at Ibadan Nigeria, and also to describe reasons why they opt for this choice and their concerns. Methods This was a descriptive study that retrospectively reviewed all records of the Implanon acceptors from January 2006 to December 2009 at University College Hospital Ibadan, Nigeria. Results One hundred and twenty-eight women accepted Implanon as a modern contraception accounting 4.3% of the total number of clients seen （2 972） during the period. The age range of the client that accepted Implanon was 26-43 years with a mean of 33.6 ±2.4 years. Of the 128 Implanon acceptors, 101 （78.9%） had used other contraceptive methods before. The commonest reason for switching to Implanon by clients was failure of the contraceptive method that was previously used （32.7%）. Within the first year follow-up of insertion, none of the Implanon acceptors had expressed desire for removal due to any of the side effects, and none contraceptive failure was observed during their follow-up evaluation. Conclusion The findings suggest that Implanon could safely be used by all women of reproductive age group including those who desire future fertility.
